Searchable abstracts of presentations at key conferences in endocrinology

ea0028p158 | Nursing practise | SFEBES2012

Adequacy of documented evidence of education in glucocorticoid deficient patients and subsequent nurse-led initiatives

Andrew Julie , May Sophie , Murray Robert

Background: Acute adrenal insufficiency leads to potentially life threatening crises if increases in steroids are delayed or insufficient. The patient is central to early increases in dosage and informing Healthcare Professionals of their steroid-dependency.Methods: To assess adequacy of information given to cortisol deficient patients we performed an audit of case notes documentation. The audit was performed over four weeks, involving 32 patients from t...

ea0034p295 | Pituitary | SFEBES2014

Can 0900 h serum cortisol levels be used to predict patient's response to the insulin tolerance test?

Kyriakakis Nikolaos , Appleton Elizabeth , Andrew Julie , Murray Robert

Aim: The insulin tolerance test (ITT) is considered the gold standard test in assessing the integrity of the hypothalamic–pituitary–adrenal (HPA) axis. The aim of this study is to evaluate if the 0900 h cortisol levels can be predictive of the patient’s response to hypoglycaemia, minimizing the use of the ITT as it is labour, intensive and unpleasant for the patient.Methods: This is a retrospective study of 110 ITTs performed at the Endocr...

ea0034p412 | Thyroid | SFEBES2014

Are patients aware of the risk of agranulocytosis when taking antithyroid drugs?

Chau Vincent , Andrew Julie , Ward Emma , Ajjan Ramzi , Murray Robert

Background: Hyperthyroidism affects 1.3% of the population. The antithyroid drugs (ATD), carbimazole and propylthiouracil, can induce agranulocytosis, a rare but potentially life threatening side-effect with a prevalence of 0.10–0.15%. We assessed the adequacy of our patient’s knowledge of this side-effect.Methods: Patients on ATD completed a questionnaire before attending clinic. The questionnaire consisted of nine questions detailing informat...

ea0021p56 | Clinical practice/governance and case reports | SFEBES2009

Investigating for Cushing's syndrome in a patient with increased BMI on rifampicin

Ali Mansoor , Andrew Julie , Mbagaya Wycliffe , Orme Steve

A 39-year-old rugby league player was admitted with back pain to an Endocrinology/General Medicine ward. He was diagnosed with osteomyelitis of the spine and was treated with antibiotic. During his prolonged in-patient stay (6 weeks i.v. antibiotic treatment), the presence of purple striae on his lower abdomen was noted. Although he did not have other classical features of a Cushing’s syndrome including proximal myopathy, he had an increased BMI (38 kg/m2) and ...